# Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?

> **NCT01040819** · PHASE4 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 25 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT01040819
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-10
- **Final completion:** 2011-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01040819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01040819, "Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01040819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*